SB 1642 allows healthcare providers to issue initial opioid prescriptions for acute pain in "divided quantities" (e.g., splitting a seven-day supply into two parts to be filled on different dates), while still counting as a single prescription under the seven-day limit. It directly affects doctors and other prescribers who treat acute pain with opioids, requiring them to use immediate-release drugs at the lowest effective dose. Key provisions include mandating "do not fill until" dates for the second part of the divided prescription and requiring documentation of the rationale for splitting. The bill maintains existing requirements like seven-day limits, thorough patient consultations about opioid risks, and prescription monitoring checks.
SB 1427 requires all Oklahoma children to be screened for type 1 diabetes during routine checkups at ages 5 and 12 by their primary care providers, using accepted medical practices. The bill mandates that these screenings be reimbursed through Oklahoma's Medicaid program (pending federal approval) and directs the State Department of Health to seek additional funding to support the screenings. The Oklahoma Health Care Authority Board and State Commissioner of Health must create implementing rules for reimbursement and screening protocols. This law applies to all children in Oklahoma and takes effect November 1, 2026.
This bill approves specific rule changes proposed by the Oklahoma Medical Marijuana Authority regarding the state's medical cannabis program. By passing this resolution, the legislature officially adopts these new regulations, which will guide how medical marijuana is distributed and managed. The Oklahoma Secretary of State is tasked with sending a copy of the approved rules to the Governor and the official state register. This action formalizes the authority's operational guidelines without altering the underlying laws governing medical marijuana use.
SB 1447 prohibits the Oklahoma Employees Insurance Plan from awarding contracts to pharmacy benefits managers (PBMs) that have settled lawsuits, been fined, or faced judgments exceeding $4 million in the past five years. The bill requires that state contract evaluations must favor PBMs headquartered in Oklahoma for at least one year and disfavor PBMs with corporate ties to health insurers, retail pharmacies, specialty pharmacies, mail-order pharmacies, or drug manufacturers. Contracted PBMs must also certify compliance with Oklahoma’s health information laws and maintain SOC 2 Type 2 security certification. The law takes effect November 1, 2026.
SB 1484 requires Oklahoma medical examiners to conduct standardized investigations for sudden infant or young deaths (including SIDS, SUID, SDY, and SADS), mandating autopsies when needed, review of medical records, and documentation of recent immunizations. It requires medical examiners to notify parents or legal guardians before investigations begin and grants them the right to refuse parts of the process unless a crime is suspected. The bill expands mandatory investigations to cover all sudden unexplained deaths in children under 20, requiring reporting to a national CDC/NIH registry and sharing findings with the State Department of Health. This directly affects medical examiners, parents/guardians of deceased children, and state health authorities through new procedural requirements.
SB 1565 requires Oklahoma's Medicaid program to include nutrition support services for pregnant and postpartum women with diet-related conditions or high-risk pregnancy factors. It mandates medically tailored home-delivered meals designed by dietitians to meet specific medical needs, along with optional nutritional counseling, to improve maternal health outcomes. The bill authorizes Oklahoma Health Care Authority to use federal funds from the CMS Transforming Maternal Health (TMaH) Model exclusively for these services. The law takes effect July 1, 2026, and is designated as an emergency measure.
SB 1500 requires pharmacy benefits managers (PBMs) and other payors to pay pharmacies within 30 days for "clean claims" (properly submitted claims without issues). It prohibits PBMs from conditioning payments on post-transaction reconciliations or shifting payment delays to pharmacies, and mandates transparent accounting for payments. The bill also authorizes Oklahoma’s Attorney General to impose fines for violations and voids contracts that violate these rules. These changes directly affect pharmacies (as providers) and PBMs/insurers (as payors) by standardizing payment timelines and reducing financial risk for pharmacies.
SB 1644 would require Oklahoma's health department to add alpha-gal syndrome (AGS) to the official list of reportable diseases, meaning doctors, nurses, and clinical laboratories must report diagnosed cases to the state health department. AGS is a condition causing allergic reactions to red meat and other animal products, which currently lacks formal tracking in Oklahoma. The bill updates existing health reporting laws to include AGS and makes the language gender-neutral. It would take effect on November 1, 2026.
SB 444 updates Oklahoma's rules for disposing of expired, unused, or abandoned controlled substances (like prescription medications). It allows regular people (ultimate users) to safely dispose of their own medications without registration, permits hospice programs to handle medications from deceased patients under federal rules, and removes previous restrictions on disposal methods. All disposal must follow federal guidelines (21 C.F.R. Part 1317), require specific forms for hospice cases, and be documented for state/federal review. The law takes effect November 1, 2025.
SB 933 requires Oklahoma hospitals and ambulatory surgical centers to adopt policies using surgical smoke evacuation systems during procedures likely to generate surgical smoke. These systems must capture smoke at the source before it reaches staff or patients' eyes or lungs. The bill defines "surgical smoke" as gaseous by-products like plume or bio-aerosols produced during energy-based surgical procedures. The policy must be implemented by November 1, 2025, to prevent exposure to this airborne hazard.
